Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

FDA Priority Review for Pfizer investigational leukaemia drug

February 22, 2017 Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review

Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …
News
naloxone

FDA rejects Amphastar’s application for NDA for intranasal overdose treatment

February 21, 2017 Research and Development Amphastar, FDA

Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …
News
aging_-_hand

Anti-aging study reveals role of mitochondria pointing towards new medicine

February 21, 2017 Manufacturing and Production, Research and Development Anti-aging, SkQ1, anti aging, mitochondria

A joint study between researchers from Russia and Sweden has revealed the extent to which mitochondria play a role in …
News

BlackThorn Therapeutics bring in new CEO

February 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics

BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …
Appointment
celgene_1_02

Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis

February 20, 2017 Research and Development, Sales and Marketing Celgene, multiple sclerosis

Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …
News
novartis_appointment

New Managing Director of UK & Ireland for Novartis

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …
Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …
News
astrazeneca_logo_building

AstraZeneca’s drug scores positive results against chemo in breast cancer

February 17, 2017 Medical Communications, Research and Development AstraZeneca

AstraZeneca announced that its drug, Lynpara (olaparib), had positive results for a recent Phase 3 trial when tested against standard …
News
donald_trump_september_3_2015

What does Trump’s victory mean for the pharma, biotech and healthcare sectors?

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Trump

After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …
Feature
mosquito

Malaria vaccine displays 100% success rate in clinical trial

February 16, 2017 Research and Development Vaccine, malaria

A malaria vaccine, jointly developed by the University of Tübingen and biotech company Sanaria Inc., has demonstrated in a small pool …
News
shutterstock_159488225

New cancer drug could give hope to non-responsive patients

February 15, 2017 Research and Development Cancer

A new dual action drug developed as part of a collaboration between biopharmaceutical oncology firm Almac Discovery and The Royal …
News

Stada encourages bidding war, with figure of €3.5 billion mooted

February 15, 2017 Research and Development, Sales and Marketing Advent International, Cinven, Stada

Stada, the German generic drugmaker, has received two offers for takeover, with one estimated to be €3.5 billion, thought to …
News
shutterstock_146497481

US panel endorses human embryo gene editing, with caveats

February 15, 2017 Research and Development crispr, gene editing

Gene editing in human embryos has been given the go-ahead by a panel of experts from the US National Academy …
News
merck_entrance

MSD’s Alzheimer’s drug failure undermines potential treatment pathway

February 15, 2017 Research and Development Alzheimer's, MSD, Merck

MSD, known as Merck in North America, has announced that it has been forced to cancel a Phase 2/3 trial …
News
device_magnetic

Magnetic implant could revolutionise drug delivery

February 15, 2017 Research and Development University of British Colombia, University of British Colombia - Device next to Canadian one dollar coin., magnetic implant

Researchers from the University of British Columbia have invented a new method of drug delivery that relies on magnets to …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026